- Home
- BAOS vs ISPC Comparison
BAOS vs ISPC Comparison
Compare BAOS & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAOS | ISPC |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.7M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BAOS | ISPC |
|---|---|---|
| Price | $2.64 | $2.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 78.3K | 66.1K |
| Earning Date | 05-08-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,928,998.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.98 | $0.10 |
| 52 Week High | $5.40 | $6.77 |
Technical Indicators
Market Signals| Indicator | BAOS | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 44.40 |
| Support Level | $2.45 | $2.39 |
| Resistance Level | $2.82 | $4.49 |
| Average True Range (ATR) | 0.19 | 0.23 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 21.31 | 43.86 |
Price Performance
Historical ComparisonAbout BAOS Baosheng Media Group Holdings
Baosheng Media Group Holdings Ltd is a China-based online marketing solution provider. The company provides internet marketing, short-video and V-log marketing, content production and operation, e-commerce marketing, data platform services, and AI technology-related services. It also offers customized marketing solutions and channel marketing services through partnerships with internet platforms such as Tencent, Alibaba, ByteDance, and Kuaishou.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.